Transparency Market
Research Reports incorporated a definite business overview and investigation
inclines on "Bioinformatics In IVD Testing Market". This report likewise
incorporates more illumination about fundamental review of the business
including definitions, requisitions and worldwide business sector industry
structure.
Research
efforts in last two decades have provided us huge amount of genomic information
for almost each and every form of life. Bioinformatics is a multidisciplinary
research field that combines computer science, biology, statistics and
mathematics for the management of biological information.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/bioinformatics-in-ivd-testing.html
The software and
applications used in bioinformatics is used to gather, analyze, store and
integrate genetic and biological information which can later be applied to gene
based drug developments. Computer diagnostics offers wide opportunities to
clinicians and pathologists in detecting difficult to culture pathogenic
bacteria and viruses to reveal epidemiology and disease prevalence.
Bioinformatics based testing have made a major impact and contribution in
uplifting cancer diagnostics and therapeutic management.
Traditionally in-vitro
diagnostic tests earlier were generally performed and interpreted by clinical
and lab technicians but with the growing prevalence of rare and life
threatening diseases such as HIV, cancer among others have created a huge
market for DNA sequencing, mass spectroscopy, genomics and proteomics based
technology and devices. Many IT giants such as IBM and others are collaborating
with laboratory testing vendors and manufacturers for developing specialized
algorithms and software pertaining to specific disease or conditions which in
near future would complement the skills of human based test interpretations and
diagnosis.
One of the novel
technological innovation in this field comprises IBM’s Watson supercomputer
which uses specific algorithms and previously stored patient databases in
analyzing and recommending the best suitable treatment and therapy on a case to
case basis. Such technological up gradations have not only let researchers and
scientists in disease analysis but also divulged insight to questions as to why
a person gets affected by certain diseases such as cancers or tumors and
difference in therapeutic responses from one person to other.
In June 2013, EMBL and
EMBL-EBI have joined Global Alliance, an organization that partners with
different healthcare providers and research institutes which will share their
findings, databases and product description among other Global Alliance
partners for further comments and refinement. Such collaboration and alliances
enable various research organizations and institutes for developing
interoperable information-technology platforms for biomedicine for novel and
low cost drug developments and detecting the root cause for some of the
incurable diseases such as Alzheimer’s disease and other similar diseases.
Major drivers that are compelling the growth for this market include
collaboration of bioinformatics and in-vitro diagnostic companies with
information technology companies for designing and developing specific software
and algorithms which can be practically implemented in detecting and diagnosing
specific un-curable or inherited diseases.
The reduced cost of
genome sequencing in past few years is fueling the flow of information with
respect to genetic basis of health and diseases. Lack of norms and government
interventions for sharing and protecting data of patients are one of the
prominent reasons for slow uptake of genomic medicines in clinical setting.
Lack of awareness about biobanks and other similar depositories which stores
and protect patient history and records also a major restraint for
bioinformatics based IVD testing market. The global market for bioinformatics
in IVD testing can be segmented on the basis of test types such as blood based
tests and tissue based tests. Apart from this they can also be further
segmented on the basis of disease type and recent trends with respect to bioinformatics
based test such as mass spectroscopy based test, genome sequencing tests as
well as prominent software types.
Some of the prominent
IT and IVD players in the market encompasses Aperio Technologies, Inc., Chronix
Biomedical Inc., Medtronic Inc., Everist Genomics, Inc., Signal Genetics,
Silicon Valley Biosystems, Biodiscovery, Inc., IBM Corporation and
others.
This research report
analyzes this market depending on its market segments, major geographies, and
current market trends. Geographies analyzed under this research report
include
- North
America
- Asia
Pacific
- Europe
- Rest
of the World
This report provides comprehensive
analysis of
- Market
growth drivers
- Factors
limiting market growth
- Current
market trends
- Market
structure
- Market
projections for upcoming years
This report is a
complete study of current trends in the market, industry growth drivers, and
restraints. It provides market projections for the coming years. It includes
analysis of recent developments in technology, Porter’s five force model
analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
More
Reports on Medical Devices Market: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
About Us:-
Transparency
Market Research (TMR) is a market intelligence company providing global
business research reports and consulting services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking insights
for thousands of decision-makers.
Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Browse
Market Research Report:-
No comments:
Post a Comment